|
|
Line 158: |
Line 158: |
| <section class="features"> | | <section class="features"> |
| <article> | | <article> |
− | <a href="#" class="image"><img src="https://static.igem.org/mediawiki/2017/0/03/Diagram_Models_%283%29.jpg" title="Click to return back to the top." /></a> | + | <a href="#" class="image"><img src="https://static.igem.org/mediawiki/2017/c/cc/Diagram_Models_%283%29-1.jpg" /></a> |
| <h3 class="major">Figure 1</h3> | | <h3 class="major">Figure 1</h3> |
| <p>Our gene production construct is modeled to produce COX-2 and c-Myc, which we used to simulate conditions in human bodies when these proteins are overproduced, in the case of CRC. The construct consists of an Anderson promoter, a ribosomal binding site, a COX-2 gene/c-Myc gene, and a terminator.</p> | | <p>Our gene production construct is modeled to produce COX-2 and c-Myc, which we used to simulate conditions in human bodies when these proteins are overproduced, in the case of CRC. The construct consists of an Anderson promoter, a ribosomal binding site, a COX-2 gene/c-Myc gene, and a terminator.</p> |